Literature DB >> 17891003

Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review.

Donald S Fong1, Aniz Girach, April Boney.   

Abstract

PURPOSE: To review the literature on limitations and adverse effects associated with scatter or panretinal laser photocoagulation (PRP) for diabetic retinopathy (DR).
DESIGN: Literature review.
RESULTS: Scatter laser photocoagulation is associated with moderate visual loss, some diminished visual field, reduced color vision, and reduced contrast sensitivity.
CONCLUSIONS: Scatter laser photocoagulation has been shown to reduce the risk of severe visual loss from proliferative DR. However, scatter treatment is associated with some decline in visual function. These effects should be studied more extensively and should be considered when comparing pharmacologic treatments for proliferative DR.

Entities:  

Mesh:

Year:  2007        PMID: 17891003     DOI: 10.1097/IAE.0b013e318042d32c

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  50 in total

1.  Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes.

Authors:  Wendy W Harrison; Marcus A Bearse; Jason S Ng; Nicholas P Jewell; Shirin Barez; Dennis Burger; Marilyn E Schneck; Anthony J Adams
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-09       Impact factor: 4.799

2.  Changes in pupil size following panretinal retinal photocoagulation: conventional laser vs pattern scan laser (PASCAL).

Authors:  I Yilmaz; I Perente; B Saracoglu; A T Yazici; M Taskapili
Journal:  Eye (Lond)       Date:  2016-07-08       Impact factor: 3.775

3.  [Navigated focal retinal laser therapy using the NAVILAS® system for diabetic macula edema].

Authors:  M Kernt; R Cheuteu; R G Liegl; F Seidensticker; S Cserhati; C Hirneiss; C Haritoglou; A Kampik; M Ulbig; A S Neubauer
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

Review 4.  Imaging of the parafoveal capillary network in diabetes.

Authors:  Gábor György Deák; Ursula Schmidt-Erfurth
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

5.  An experimental platform for systemic drug delivery to the retina.

Authors:  Matthew Campbell; Anh T H Nguyen; Anna-Sophia Kiang; Lawrence C S Tam; Oliviero L Gobbo; Christian Kerskens; Sorcha Ni Dhubhghaill; Marian M Humphries; G-Jane Farrar; Paul F Kenna; Peter Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

6.  TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.

Authors:  Hossein Ameri; Hua Liu; Rong Liu; Yonju Ha; Adriana A Paulucci-Holthauzen; Shuqun Hu; Massoud Motamedi; Bernard F Godley; Ronald G Tilton; Wenbo Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-10       Impact factor: 4.799

7.  Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States.

Authors:  Jeffrey R Willis; Quan V Doan; Michelle Gleeson; Zdenka Haskova; Pradeep Ramulu; Lawrence Morse; Ronald A Cantrell
Journal:  JAMA Ophthalmol       Date:  2017-09-01       Impact factor: 7.389

Review 8.  Emerging Concepts in the Treatment of Diabetic Retinopathy.

Authors:  Michael Patrick Ellis; Daniella Lent-Schochet; Therlinder Lo; Glenn Yiu
Journal:  Curr Diab Rep       Date:  2019-11-20       Impact factor: 4.810

9.  Angiogenic and Immunologic Proteins Identified by Deep Proteomic Profiling of Human Retinal and Choroidal Vascular Endothelial Cells: Potential Targets for New Biologic Drugs.

Authors:  Justine R Smith; Larry L David; Binoy Appukuttan; Phillip A Wilmarth
Journal:  Am J Ophthalmol       Date:  2018-03-17       Impact factor: 5.258

Review 10.  Evaluation of Laser Effects on the Human Body After Laser Therapy.

Authors:  Ensieh Khalkhal; Mohammadreza Razzaghi; Mohammad Rostami-Nejad; Majid Rezaei-Tavirani; Hazhir Heidari Beigvand; Mostafa Rezaei Tavirani
Journal:  J Lasers Med Sci       Date:  2020-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.